Detalles de la búsqueda
1.
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
Trials
; 22(1): 363, 2021 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34034784
Resultados
1 -
1
de 1
1
Próxima >
>>